

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.12512030 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.91380397 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.91380397 |
| 4 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.60048884 |
| 5 | DNA unwinding involved in DNA replication (GO:0006268) | 4.53509467 |
| 6 | viral transcription (GO:0019083) | 4.51208654 |
| 7 | translational termination (GO:0006415) | 4.33522607 |
| 8 | ribosomal small subunit assembly (GO:0000028) | 4.33042927 |
| 9 | regulation of gamma-delta T cell activation (GO:0046643) | 4.29662115 |
| 10 | maturation of SSU-rRNA (GO:0030490) | 4.27386006 |
| 11 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 4.23556386 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.22901509 |
| 13 | negative regulation of RNA splicing (GO:0033119) | 4.07769051 |
| 14 | pre-miRNA processing (GO:0031054) | 3.92882017 |
| 15 | response to muramyl dipeptide (GO:0032495) | 3.89085639 |
| 16 | ribosomal small subunit biogenesis (GO:0042274) | 3.86816842 |
| 17 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.83398959 |
| 18 | translational elongation (GO:0006414) | 3.81167266 |
| 19 | mannose metabolic process (GO:0006013) | 3.79735549 |
| 20 | regulation of translational fidelity (GO:0006450) | 3.74321311 |
| 21 | regulation of histone H3-K27 methylation (GO:0061085) | 3.73730809 |
| 22 | negative regulation of mRNA processing (GO:0050686) | 3.64509773 |
| 23 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.64240062 |
| 24 | positive thymic T cell selection (GO:0045059) | 3.58011916 |
| 25 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.56613134 |
| 26 | response to peptidoglycan (GO:0032494) | 3.56098632 |
| 27 | translational initiation (GO:0006413) | 3.48114523 |
| 28 | negative regulation of mRNA metabolic process (GO:1903312) | 3.44906706 |
| 29 | alternative mRNA splicing, via spliceosome (GO:0000380) | 3.43813941 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 3.37770830 |
| 31 | positive regulation by symbiont of host defense response (GO:0052509) | 3.37770830 |
| 32 | modulation by symbiont of host defense response (GO:0052031) | 3.37770830 |
| 33 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.37770830 |
| 34 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.37770830 |
| 35 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.37770830 |
| 36 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.35881783 |
| 37 | cellular protein complex disassembly (GO:0043624) | 3.35544718 |
| 38 | negative regulation of histone methylation (GO:0031061) | 3.35190650 |
| 39 | thymic T cell selection (GO:0045061) | 3.34541061 |
| 40 | apoptotic process involved in morphogenesis (GO:0060561) | 3.31395207 |
| 41 | response to interleukin-15 (GO:0070672) | 3.25287445 |
| 42 | viral life cycle (GO:0019058) | 3.24414198 |
| 43 | negative regulation of cell size (GO:0045792) | 3.22586197 |
| 44 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.20207921 |
| 45 | protein complex disassembly (GO:0043241) | 3.17135677 |
| 46 | interferon-gamma secretion (GO:0072643) | 3.16764876 |
| 47 | leukocyte aggregation (GO:0070486) | 3.16661451 |
| 48 | DNA duplex unwinding (GO:0032508) | 3.13905449 |
| 49 | DNA geometric change (GO:0032392) | 3.12974128 |
| 50 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.10817972 |
| 51 | protein targeting to ER (GO:0045047) | 3.10763125 |
| 52 | negative T cell selection (GO:0043383) | 3.09866023 |
| 53 | negative thymic T cell selection (GO:0045060) | 3.09571444 |
| 54 | cotranslational protein targeting to membrane (GO:0006613) | 3.07913315 |
| 55 | nuclear pore complex assembly (GO:0051292) | 3.07710266 |
| 56 | positive regulation of B cell differentiation (GO:0045579) | 3.07679668 |
| 57 | formation of translation preinitiation complex (GO:0001731) | 3.07595758 |
| 58 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.06625769 |
| 59 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.02855135 |
| 60 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.02682120 |
| 61 | T cell selection (GO:0045058) | 3.02143012 |
| 62 | nuclear pore organization (GO:0006999) | 3.01798235 |
| 63 | Golgi transport vesicle coating (GO:0048200) | 3.01499429 |
| 64 | COPI coating of Golgi vesicle (GO:0048205) | 3.01499429 |
| 65 | protein localization to kinetochore (GO:0034501) | 3.00369993 |
| 66 | regulation of chromatin binding (GO:0035561) | 3.00206762 |
| 67 | mitotic nuclear envelope disassembly (GO:0007077) | 2.99726954 |
| 68 | response to laminar fluid shear stress (GO:0034616) | 2.96278330 |
| 69 | histone H3-K4 trimethylation (GO:0080182) | 2.95594433 |
| 70 | ribosomal large subunit biogenesis (GO:0042273) | 2.94436301 |
| 71 | detection of bacterium (GO:0016045) | 2.94208068 |
| 72 | modulation by virus of host process (GO:0019054) | 2.92683592 |
| 73 | positive T cell selection (GO:0043368) | 2.92509716 |
| 74 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.92299974 |
| 75 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.90478711 |
| 76 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.89964697 |
| 77 | embryonic process involved in female pregnancy (GO:0060136) | 2.89761763 |
| 78 | activation of Rac GTPase activity (GO:0032863) | 2.89258585 |
| 79 | ribosome biogenesis (GO:0042254) | 2.89165956 |
| 80 | detection of other organism (GO:0098543) | 2.88908150 |
| 81 | macromolecular complex disassembly (GO:0032984) | 2.88110292 |
| 82 | B cell receptor signaling pathway (GO:0050853) | 2.87423193 |
| 83 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.87001232 |
| 84 | modulation by symbiont of host cellular process (GO:0044068) | 2.86735849 |
| 85 | negative regulation of gene expression, epigenetic (GO:0045814) | 2.86574083 |
| 86 | NIK/NF-kappaB signaling (GO:0038061) | 2.85956211 |
| 87 | histone H3-K4 methylation (GO:0051568) | 2.85197324 |
| 88 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.85177698 |
| 89 | protein localization to endoplasmic reticulum (GO:0070972) | 2.84442182 |
| 90 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.84127730 |
| 91 | positive regulation of histone deacetylation (GO:0031065) | 2.83342396 |
| 92 | negative regulation of cell killing (GO:0031342) | 2.82866897 |
| 93 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.82866897 |
| 94 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.82497966 |
| 95 | nuclear envelope disassembly (GO:0051081) | 2.82412834 |
| 96 | membrane disassembly (GO:0030397) | 2.82412834 |
| 97 | germinal center formation (GO:0002467) | 2.81424802 |
| 98 | pentose-phosphate shunt (GO:0006098) | 2.81044381 |
| 99 | ncRNA 3-end processing (GO:0043628) | 2.80811896 |
| 100 | mRNA catabolic process (GO:0006402) | 2.80097169 |
| 101 | RNA catabolic process (GO:0006401) | 2.77972017 |
| 102 | chromatin silencing (GO:0006342) | 2.77569657 |
| 103 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.77553944 |
| 104 | regulation of translational termination (GO:0006449) | 2.77292025 |
| 105 | protein localization to endosome (GO:0036010) | 2.76900548 |
| 106 | ribosome assembly (GO:0042255) | 2.74721099 |
| 107 | cellular response to virus (GO:0098586) | 2.74525942 |
| 108 | mitotic chromosome condensation (GO:0007076) | 2.73455814 |
| 109 | tolerance induction (GO:0002507) | 2.73348850 |
| 110 | IMP biosynthetic process (GO:0006188) | 2.72746348 |
| 111 | negative regulation of stress fiber assembly (GO:0051497) | 2.72739017 |
| 112 | regulation of histone H3-K9 methylation (GO:0051570) | 2.72501780 |
| 113 | DNA strand elongation (GO:0022616) | 2.72301488 |
| 114 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.71508063 |
| 115 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.70811619 |
| 116 | T cell homeostasis (GO:0043029) | 2.68492563 |
| 117 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.68351618 |
| 118 | translesion synthesis (GO:0019985) | 2.67134639 |
| 119 | macrophage activation involved in immune response (GO:0002281) | 2.66456653 |
| 120 | neutrophil activation involved in immune response (GO:0002283) | 2.65567034 |
| 121 | folic acid metabolic process (GO:0046655) | 2.64922524 |
| 122 | regulation of histone H3-K4 methylation (GO:0051569) | 2.64767172 |
| 123 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.64362595 |
| 124 | regulation of leukocyte degranulation (GO:0043300) | 2.64216477 |
| 125 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.64144826 |
| 126 | DNA replication initiation (GO:0006270) | 2.61062405 |
| 127 | regulation of B cell differentiation (GO:0045577) | 2.60951621 |
| 128 | determination of adult lifespan (GO:0008340) | 2.60412183 |
| 129 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.58774767 |
| 130 | nucleobase biosynthetic process (GO:0046112) | 2.58249364 |
| 131 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.57891449 |
| 132 | histone H3-K36 demethylation (GO:0070544) | 2.57127698 |
| 133 | nuclear envelope organization (GO:0006998) | 2.55795675 |
| 134 | mRNA stabilization (GO:0048255) | 2.55138811 |
| 135 | RNA stabilization (GO:0043489) | 2.55138811 |
| 136 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.54803655 |
| 137 | regulation of histone methylation (GO:0031060) | 2.53829832 |
| 138 | cellular response to interleukin-4 (GO:0071353) | 2.53507003 |
| 139 | inner cell mass cell proliferation (GO:0001833) | 2.53364926 |
| 140 | cell-substrate adherens junction assembly (GO:0007045) | 2.52220659 |
| 141 | focal adhesion assembly (GO:0048041) | 2.52220659 |
| 142 | IMP metabolic process (GO:0046040) | 2.51829232 |
| 143 | cellular response to interleukin-15 (GO:0071350) | 2.51474775 |
| 144 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.50911601 |
| 145 | regulation of gene silencing by miRNA (GO:0060964) | 2.50911601 |
| 146 | regulation of gene silencing by RNA (GO:0060966) | 2.50911601 |
| 147 | regulation of ARF GTPase activity (GO:0032312) | 2.50567870 |
| 148 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.50528845 |
| 149 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.49933075 |
| 150 | establishment of skin barrier (GO:0061436) | 2.49467880 |
| 151 | adherens junction assembly (GO:0034333) | 2.49410364 |
| 152 | regulation of water loss via skin (GO:0033561) | 2.46910221 |
| 153 | regulation of mast cell degranulation (GO:0043304) | 2.46418779 |
| 154 | maternal placenta development (GO:0001893) | 2.45880530 |
| 155 | proline biosynthetic process (GO:0006561) | 2.45625559 |
| 156 | negative regulation of viral release from host cell (GO:1902187) | 2.45338080 |
| 157 | histone H4 deacetylation (GO:0070933) | 2.45143687 |
| 158 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.44777420 |
| 159 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.44227738 |
| 160 | regulation of defense response to virus by virus (GO:0050690) | 2.40721127 |
| 161 | snRNA metabolic process (GO:0016073) | 2.36828125 |
| 162 | response to interleukin-4 (GO:0070670) | 2.35061611 |
| 163 | pinocytosis (GO:0006907) | 2.34985183 |
| 164 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.34342657 |
| 165 | regulation of early endosome to late endosome transport (GO:2000641) | 2.32821175 |
| 166 | negative regulation of phagocytosis (GO:0050765) | 2.32399358 |
| 167 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.31355756 |
| 168 | activation of JUN kinase activity (GO:0007257) | 2.31031159 |
| 169 | glucose catabolic process (GO:0006007) | 2.29844084 |
| 170 | negative regulation of interleukin-12 production (GO:0032695) | 2.29839268 |
| 171 | detection of external biotic stimulus (GO:0098581) | 2.29608849 |
| 172 | negative regulation of innate immune response (GO:0045824) | 2.29532980 |
| 173 | NADPH regeneration (GO:0006740) | 2.29485524 |
| 174 | immunoglobulin mediated immune response (GO:0016064) | 2.27738013 |
| 175 | regulation of RNA export from nucleus (GO:0046831) | 2.26198616 |
| 176 | megakaryocyte development (GO:0035855) | 2.25448480 |
| 177 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.25290853 |
| 178 | stress fiber assembly (GO:0043149) | 2.25007912 |
| 179 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.24815865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.98174045 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.76315606 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.97499895 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.80068932 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.79360525 |
| 6 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.69702158 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.63784397 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.63192265 |
| 9 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.23197500 |
| 10 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.20439317 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.17518442 |
| 12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.07866740 |
| 13 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.06533328 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.02887093 |
| 15 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.02309120 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.95062465 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.88947292 |
| 18 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.85324183 |
| 19 | UTX_26944678_Chip-Seq_JUKART_Human | 1.85031665 |
| 20 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.83947487 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 1.82370729 |
| 22 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.75872762 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.73907765 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.72333640 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.64827404 |
| 26 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63579083 |
| 27 | MYB_26560356_Chip-Seq_TH1_Human | 1.63274864 |
| 28 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.62704744 |
| 29 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.62480240 |
| 30 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.62434661 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62284910 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 1.61140820 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.61000172 |
| 34 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.60025862 |
| 35 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.58927211 |
| 36 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.57650129 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.54792778 |
| 38 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.52539923 |
| 39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52536884 |
| 40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51831289 |
| 41 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.50281269 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.48002706 |
| 43 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.46627839 |
| 44 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.46019937 |
| 45 | KDM2B_26808549_Chip-Seq_K562_Human | 1.45146336 |
| 46 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.43793087 |
| 47 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.42587197 |
| 48 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.41753338 |
| 49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40487075 |
| 50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.37928099 |
| 51 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.37700423 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37639828 |
| 53 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35942059 |
| 54 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.35441185 |
| 55 | MAF_26560356_Chip-Seq_TH2_Human | 1.35352083 |
| 56 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.34365208 |
| 57 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.32993945 |
| 58 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30877039 |
| 59 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.29253229 |
| 60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28941982 |
| 61 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.28387236 |
| 62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27957732 |
| 63 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.27654580 |
| 64 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.27552498 |
| 65 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.27383361 |
| 66 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.26849750 |
| 67 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.24419614 |
| 68 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.23932903 |
| 69 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.23457673 |
| 70 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.23429035 |
| 71 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.22222718 |
| 72 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21766828 |
| 73 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21281966 |
| 74 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.20927721 |
| 75 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.20674368 |
| 76 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20548181 |
| 77 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.20218913 |
| 78 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.20160993 |
| 79 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.19224049 |
| 80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18671685 |
| 81 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.18582117 |
| 82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18376478 |
| 83 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17258934 |
| 84 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16933447 |
| 85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.16918696 |
| 86 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.16889192 |
| 87 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16334437 |
| 88 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.15244331 |
| 89 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.15064773 |
| 90 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.14765383 |
| 91 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.14570574 |
| 92 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.14042745 |
| 93 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.13974245 |
| 94 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13652261 |
| 95 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.13366533 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.12588380 |
| 97 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11844529 |
| 98 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.11644391 |
| 99 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.11548219 |
| 100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11541437 |
| 101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10734467 |
| 102 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08166386 |
| 103 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.07576603 |
| 104 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.07073516 |
| 105 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.06074210 |
| 106 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04973180 |
| 107 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.04524456 |
| 108 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03850915 |
| 109 | P68_20966046_ChIP-Seq_HELA_Human | 1.02529417 |
| 110 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02517345 |
| 111 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.02143135 |
| 112 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.02018075 |
| 113 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01964577 |
| 114 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.01815269 |
| 115 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00287165 |
| 116 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99994927 |
| 117 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99406241 |
| 118 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.98299383 |
| 119 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98276065 |
| 120 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98040621 |
| 121 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97215918 |
| 122 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97208424 |
| 123 | ATF3_27146783_Chip-Seq_COLON_Human | 0.96458002 |
| 124 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.96193633 |
| 125 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.95995560 |
| 126 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.94641499 |
| 127 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.93925448 |
| 128 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.92888454 |
| 129 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.92340910 |
| 130 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92272995 |
| 131 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.92052617 |
| 132 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.90939639 |
| 133 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.90871315 |
| 134 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.90718564 |
| 135 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.90539515 |
| 136 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.90211647 |
| 137 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89070995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 3.51471369 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.29353357 |
| 3 | MP0005058_abnormal_lysosome_morphology | 2.84770843 |
| 4 | MP0008260_abnormal_autophagy | 2.54483852 |
| 5 | MP0010352_gastrointestinal_tract_polyps | 2.52084037 |
| 6 | MP0003111_abnormal_nucleus_morphology | 2.50313155 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 2.49724338 |
| 8 | MP0002166_altered_tumor_susceptibility | 2.47185985 |
| 9 | MP0003693_abnormal_embryo_hatching | 2.43752761 |
| 10 | MP0002796_impaired_skin_barrier | 2.42359745 |
| 11 | MP0010094_abnormal_chromosome_stability | 2.37135156 |
| 12 | MP0008057_abnormal_DNA_replication | 2.29035828 |
| 13 | MP0003172_abnormal_lysosome_physiology | 2.28267059 |
| 14 | MP0000383_abnormal_hair_follicle | 2.18643679 |
| 15 | MP0004957_abnormal_blastocyst_morpholog | 2.17460996 |
| 16 | MP0005397_hematopoietic_system_phenotyp | 2.13411201 |
| 17 | MP0001545_abnormal_hematopoietic_system | 2.13411201 |
| 18 | MP0001800_abnormal_humoral_immune | 2.07863700 |
| 19 | MP0002398_abnormal_bone_marrow | 2.06240525 |
| 20 | MP0000685_abnormal_immune_system | 2.04268880 |
| 21 | MP0004808_abnormal_hematopoietic_stem | 2.02766858 |
| 22 | MP0004947_skin_inflammation | 2.00149231 |
| 23 | MP0003077_abnormal_cell_cycle | 1.98336250 |
| 24 | MP0001873_stomach_inflammation | 1.95637047 |
| 25 | MP0010678_abnormal_skin_adnexa | 1.93606156 |
| 26 | MP0009278_abnormal_bone_marrow | 1.92999601 |
| 27 | MP0002877_abnormal_melanocyte_morpholog | 1.90593768 |
| 28 | MP0000703_abnormal_thymus_morphology | 1.87227471 |
| 29 | MP0005501_abnormal_skin_physiology | 1.86077093 |
| 30 | MP0002006_tumorigenesis | 1.84409204 |
| 31 | MP0002419_abnormal_innate_immunity | 1.84018957 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.76948152 |
| 33 | MP0002722_abnormal_immune_system | 1.74824527 |
| 34 | MP0000465_gastrointestinal_hemorrhage | 1.71307231 |
| 35 | MP0003566_abnormal_cell_adhesion | 1.65493078 |
| 36 | MP0002254_reproductive_system_inflammat | 1.65397676 |
| 37 | MP0001790_abnormal_immune_system | 1.63051812 |
| 38 | MP0005387_immune_system_phenotype | 1.63051812 |
| 39 | MP0000716_abnormal_immune_system | 1.59204153 |
| 40 | MP0002420_abnormal_adaptive_immunity | 1.58444773 |
| 41 | MP0001835_abnormal_antigen_presentation | 1.57525751 |
| 42 | MP0002723_abnormal_immune_serum | 1.55950633 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.54512100 |
| 44 | MP0001819_abnormal_immune_cell | 1.54170416 |
| 45 | MP0001216_abnormal_epidermal_layer | 1.53539886 |
| 46 | MP0003724_increased_susceptibility_to | 1.53398393 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.50324120 |
| 48 | MP0003436_decreased_susceptibility_to | 1.47499812 |
| 49 | MP0004858_abnormal_nervous_system | 1.47237029 |
| 50 | MP0002429_abnormal_blood_cell | 1.46235478 |
| 51 | MP0008058_abnormal_DNA_repair | 1.45796971 |
| 52 | MP0000490_abnormal_crypts_of | 1.45325040 |
| 53 | MP0001730_embryonic_growth_arrest | 1.45114349 |
| 54 | MP0000350_abnormal_cell_proliferation | 1.44411666 |
| 55 | MP0005076_abnormal_cell_differentiation | 1.44312798 |
| 56 | MP0004381_abnormal_hair_follicle | 1.43576616 |
| 57 | MP0008007_abnormal_cellular_replicative | 1.43286648 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.41951538 |
| 59 | MP0005671_abnormal_response_to | 1.40986704 |
| 60 | MP0002009_preneoplasia | 1.39149071 |
| 61 | MP0001348_abnormal_lacrimal_gland | 1.37478868 |
| 62 | MP0003453_abnormal_keratinocyte_physiol | 1.35447488 |
| 63 | MP0003091_abnormal_cell_migration | 1.34810645 |
| 64 | MP0000377_abnormal_hair_follicle | 1.34671626 |
| 65 | MP0003866_abnormal_defecation | 1.33669186 |
| 66 | MP0009333_abnormal_splenocyte_physiolog | 1.33412450 |
| 67 | MP0004510_myositis | 1.33339385 |
| 68 | MP0003303_peritoneal_inflammation | 1.32693506 |
| 69 | MP0010155_abnormal_intestine_physiology | 1.32262910 |
| 70 | MP0002019_abnormal_tumor_incidence | 1.29572092 |
| 71 | MP0005023_abnormal_wound_healing | 1.27938491 |
| 72 | MP0005000_abnormal_immune_tolerance | 1.27076377 |
| 73 | MP0005464_abnormal_platelet_physiology | 1.22187838 |
| 74 | MP0005451_abnormal_body_composition | 1.19988728 |
| 75 | MP0010307_abnormal_tumor_latency | 1.19637713 |
| 76 | MP0002060_abnormal_skin_morphology | 1.19606603 |
| 77 | MP0002405_respiratory_system_inflammati | 1.18148048 |
| 78 | MP0008961_abnormal_basal_metabolism | 1.16441900 |
| 79 | MP0000678_abnormal_parathyroid_gland | 1.16178673 |
| 80 | MP0005025_abnormal_response_to | 1.15580619 |
| 81 | MP0004185_abnormal_adipocyte_glucose | 1.13133743 |
| 82 | MP0003786_premature_aging | 1.09482153 |
| 83 | MP0002998_abnormal_bone_remodeling | 1.08545070 |
| 84 | MP0002148_abnormal_hypersensitivity_rea | 1.07315170 |
| 85 | MP0009785_altered_susceptibility_to | 1.07163991 |
| 86 | MP0009931_abnormal_skin_appearance | 1.06656684 |
| 87 | MP0005380_embryogenesis_phenotype | 1.06561753 |
| 88 | MP0001672_abnormal_embryogenesis/_devel | 1.06561753 |
| 89 | MP0004264_abnormal_extraembryonic_tissu | 1.05878725 |
| 90 | MP0002080_prenatal_lethality | 1.05105819 |
| 91 | MP0005310_abnormal_salivary_gland | 1.04125440 |
| 92 | MP0003984_embryonic_growth_retardation | 1.02151153 |
| 93 | MP0002086_abnormal_extraembryonic_tissu | 1.00882451 |
| 94 | MP0001851_eye_inflammation | 1.00575458 |
| 95 | MP0002088_abnormal_embryonic_growth/wei | 0.99735273 |
| 96 | MP0010771_integument_phenotype | 0.99428426 |
| 97 | MP0001853_heart_inflammation | 0.99338752 |
| 98 | MP0005666_abnormal_adipose_tissue | 0.99099081 |
| 99 | MP0000313_abnormal_cell_death | 0.97977399 |
| 100 | MP0003705_abnormal_hypodermis_morpholog | 0.96782076 |
| 101 | MP0000858_altered_metastatic_potential | 0.95664740 |
| 102 | MP0004197_abnormal_fetal_growth/weight/ | 0.95251780 |
| 103 | MP0001849_ear_inflammation | 0.91386203 |
| 104 | MP0004233_abnormal_muscle_weight | 0.90671239 |
| 105 | MP0001697_abnormal_embryo_size | 0.90545016 |
| 106 | MP0003828_pulmonary_edema | 0.89570904 |
| 107 | MP0002084_abnormal_developmental_patter | 0.89472365 |
| 108 | MP0005621_abnormal_cell_physiology | 0.86723767 |
| 109 | MP0000733_abnormal_muscle_development | 0.86468400 |
| 110 | MP0002098_abnormal_vibrissa_morphology | 0.86456980 |
| 111 | MP0000367_abnormal_coat/_hair | 0.86120747 |
| 112 | MP0000647_abnormal_sebaceous_gland | 0.85490955 |
| 113 | MP0005375_adipose_tissue_phenotype | 0.84896717 |
| 114 | MP0006082_CNS_inflammation | 0.84864172 |
| 115 | MP0000003_abnormal_adipose_tissue | 0.84315092 |
| 116 | MP0009840_abnormal_foam_cell | 0.83378491 |
| 117 | MP0002085_abnormal_embryonic_tissue | 0.82316907 |
| 118 | MP0003191_abnormal_cellular_cholesterol | 0.81139513 |
| 119 | MP0001191_abnormal_skin_condition | 0.81047561 |
| 120 | MP0002249_abnormal_larynx_morphology | 0.80150595 |
| 121 | MP0003279_aneurysm | 0.79335205 |
| 122 | MP0002933_joint_inflammation | 0.79172394 |
| 123 | MP0003656_abnormal_erythrocyte_physiolo | 0.78453914 |
| 124 | MP0008469_abnormal_protein_level | 0.78010888 |
| 125 | MP0000477_abnormal_intestine_morphology | 0.77854949 |
| 126 | MP0001845_abnormal_inflammatory_respons | 0.77771454 |
| 127 | MP0000467_abnormal_esophagus_morphology | 0.77446920 |
| 128 | MP0008877_abnormal_DNA_methylation | 0.76318557 |
| 129 | MP0008770_decreased_survivor_rate | 0.75919768 |
| 130 | MP0005390_skeleton_phenotype | 0.75462551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic otitis media (HP:0000389) | 4.31489458 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.06900358 |
| 3 | Eczematoid dermatitis (HP:0000976) | 3.78494893 |
| 4 | Abnormality of the fingertips (HP:0001211) | 3.76565850 |
| 5 | Abnormal number of erythroid precursors (HP:0012131) | 3.71469008 |
| 6 | Increased IgE level (HP:0003212) | 3.56455970 |
| 7 | Broad face (HP:0000283) | 3.28950147 |
| 8 | Recurrent viral infections (HP:0004429) | 3.24698065 |
| 9 | Panhypogammaglobulinemia (HP:0003139) | 3.23560900 |
| 10 | T lymphocytopenia (HP:0005403) | 3.16956104 |
| 11 | Reticulocytopenia (HP:0001896) | 3.02480793 |
| 12 | IgM deficiency (HP:0002850) | 2.95645761 |
| 13 | Thrombocytosis (HP:0001894) | 2.91817013 |
| 14 | Pustule (HP:0200039) | 2.90017655 |
| 15 | Abnormality of macrophages (HP:0004311) | 2.82365016 |
| 16 | Recurrent bronchitis (HP:0002837) | 2.80019186 |
| 17 | Abnormality of T cell number (HP:0011839) | 2.79757636 |
| 18 | Recurrent abscess formation (HP:0002722) | 2.77241636 |
| 19 | Ependymoma (HP:0002888) | 2.76450904 |
| 20 | Basal cell carcinoma (HP:0002671) | 2.72576482 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 2.67865962 |
| 22 | Milia (HP:0001056) | 2.65437619 |
| 23 | Pallor (HP:0000980) | 2.57534354 |
| 24 | Lip pit (HP:0100267) | 2.56071131 |
| 25 | Gastrointestinal inflammation (HP:0004386) | 2.53042453 |
| 26 | Abnormality of T cells (HP:0002843) | 2.50407510 |
| 27 | Prominent nose (HP:0000448) | 2.50243258 |
| 28 | Thin bony cortex (HP:0002753) | 2.49605950 |
| 29 | Recurrent fungal infections (HP:0002841) | 2.44530508 |
| 30 | Obstructive sleep apnea (HP:0002870) | 2.44526544 |
| 31 | Nasal polyposis (HP:0100582) | 2.38710117 |
| 32 | Inflammation of the large intestine (HP:0002037) | 2.36314929 |
| 33 | Distal lower limb amyotrophy (HP:0008944) | 2.35673367 |
| 34 | Long palpebral fissure (HP:0000637) | 2.35070668 |
| 35 | Anal stenosis (HP:0002025) | 2.29912967 |
| 36 | Verrucae (HP:0200043) | 2.29786952 |
| 37 | Papilloma (HP:0012740) | 2.29786952 |
| 38 | Sparse lateral eyebrow (HP:0005338) | 2.28973974 |
| 39 | Obstructive lung disease (HP:0006536) | 2.26780878 |
| 40 | Chronic obstructive pulmonary disease (HP:0006510) | 2.26780878 |
| 41 | Cellulitis (HP:0100658) | 2.26568408 |
| 42 | Myositis (HP:0100614) | 2.25820116 |
| 43 | Selective tooth agenesis (HP:0001592) | 2.25512102 |
| 44 | Abnormality of B cell number (HP:0010975) | 2.25172584 |
| 45 | B lymphocytopenia (HP:0010976) | 2.25172584 |
| 46 | Disproportionate tall stature (HP:0001519) | 2.23886318 |
| 47 | Increased connective tissue (HP:0009025) | 2.23362857 |
| 48 | Cerebral aneurysm (HP:0004944) | 2.23312676 |
| 49 | Macrocytic anemia (HP:0001972) | 2.22729884 |
| 50 | Hemorrhage of the eye (HP:0011885) | 2.22519270 |
| 51 | Hyperacusis (HP:0010780) | 2.22237409 |
| 52 | Stenosis of the external auditory canal (HP:0000402) | 2.22095086 |
| 53 | Colitis (HP:0002583) | 2.20699797 |
| 54 | Metaphyseal cupping (HP:0003021) | 2.19425969 |
| 55 | Long eyelashes (HP:0000527) | 2.19074213 |
| 56 | Agammaglobulinemia (HP:0004432) | 2.19068362 |
| 57 | Ureteral stenosis (HP:0000071) | 2.16336931 |
| 58 | Acute lymphatic leukemia (HP:0006721) | 2.14547753 |
| 59 | Ectropion (HP:0000656) | 2.13599801 |
| 60 | Colon cancer (HP:0003003) | 2.12239853 |
| 61 | Entropion (HP:0000621) | 2.12142006 |
| 62 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.11990026 |
| 63 | Emphysema (HP:0002097) | 2.10948919 |
| 64 | Hypertensive crisis (HP:0100735) | 2.10374101 |
| 65 | Gingivitis (HP:0000230) | 2.09401938 |
| 66 | Dysostosis multiplex (HP:0000943) | 2.08731434 |
| 67 | Mediastinal lymphadenopathy (HP:0100721) | 2.08648533 |
| 68 | Asplenia (HP:0001746) | 2.08276566 |
| 69 | Poikiloderma (HP:0001029) | 2.06932548 |
| 70 | Skin tags (HP:0010609) | 2.06404945 |
| 71 | Abnormality of oral frenula (HP:0000190) | 2.05313395 |
| 72 | Reticulocytosis (HP:0001923) | 2.04719865 |
| 73 | Lymphoma (HP:0002665) | 2.04513722 |
| 74 | Increased cerebral lipofuscin (HP:0011813) | 2.04301842 |
| 75 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.02460259 |
| 76 | Achilles tendon contracture (HP:0001771) | 2.02104656 |
| 77 | Hypochromic anemia (HP:0001931) | 2.01523260 |
| 78 | Meningitis (HP:0001287) | 2.00762308 |
| 79 | Abnormality of T cell physiology (HP:0011840) | 2.00396913 |
| 80 | Abnormality of the thoracic spine (HP:0100711) | 1.99970996 |
| 81 | Persistence of primary teeth (HP:0006335) | 1.99609026 |
| 82 | Slow saccadic eye movements (HP:0000514) | 1.99510615 |
| 83 | Amaurosis fugax (HP:0100576) | 1.97828589 |
| 84 | Heterotopia (HP:0002282) | 1.96904582 |
| 85 | Combined immunodeficiency (HP:0005387) | 1.96405028 |
| 86 | Cholecystitis (HP:0001082) | 1.94253021 |
| 87 | Abnormal gallbladder physiology (HP:0012438) | 1.94253021 |
| 88 | Pili torti (HP:0003777) | 1.94013746 |
| 89 | Progressive muscle weakness (HP:0003323) | 1.93305230 |
| 90 | Rough bone trabeculation (HP:0100670) | 1.93220368 |
| 91 | Overlapping toe (HP:0001845) | 1.92965504 |
| 92 | Vertebral compression fractures (HP:0002953) | 1.92519724 |
| 93 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.92180158 |
| 94 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.91981485 |
| 95 | Loss of speech (HP:0002371) | 1.90022763 |
| 96 | Myelodysplasia (HP:0002863) | 1.89880389 |
| 97 | Cervical subluxation (HP:0003308) | 1.89670994 |
| 98 | Oligodontia (HP:0000677) | 1.88986245 |
| 99 | Severe combined immunodeficiency (HP:0004430) | 1.88871418 |
| 100 | Proximal placement of thumb (HP:0009623) | 1.88633706 |
| 101 | Esophageal atresia (HP:0002032) | 1.88484902 |
| 102 | Skin ulcer (HP:0200042) | 1.88483805 |
| 103 | Orchitis (HP:0100796) | 1.88073526 |
| 104 | Gastrointestinal infarctions (HP:0005244) | 1.87801425 |
| 105 | Hepatosplenomegaly (HP:0001433) | 1.87706448 |
| 106 | Polygenic inheritance (HP:0010982) | 1.87704731 |
| 107 | Premature loss of primary teeth (HP:0006323) | 1.87579422 |
| 108 | Ulnar bowing (HP:0003031) | 1.87476414 |
| 109 | Medulloblastoma (HP:0002885) | 1.86741440 |
| 110 | Squamous cell carcinoma (HP:0002860) | 1.86438711 |
| 111 | Biconcave vertebral bodies (HP:0004586) | 1.85839413 |
| 112 | Lymphopenia (HP:0001888) | 1.85643134 |
| 113 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.85284593 |
| 114 | Gastrointestinal stroma tumor (HP:0100723) | 1.84011005 |
| 115 | Abnormality of the salivary glands (HP:0010286) | 1.83582767 |
| 116 | Abnormality of the nasal mucosa (HP:0000433) | 1.83034004 |
| 117 | Dislocated radial head (HP:0003083) | 1.82618779 |
| 118 | Impaired platelet aggregation (HP:0003540) | 1.82103934 |
| 119 | Abnormal platelet function (HP:0011869) | 1.82103934 |
| 120 | Broad distal phalanx of finger (HP:0009836) | 1.81408206 |
| 121 | Ureteral obstruction (HP:0006000) | 1.81198098 |
| 122 | Syringomyelia (HP:0003396) | 1.80951351 |
| 123 | Spinal cord lesions (HP:0100561) | 1.80951351 |
| 124 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.80900234 |
| 125 | Stridor (HP:0010307) | 1.80484937 |
| 126 | Easy fatigability (HP:0003388) | 1.80140743 |
| 127 | Preauricular skin tag (HP:0000384) | 1.80059242 |
| 128 | Interstitial pulmonary disease (HP:0006530) | 1.79643187 |
| 129 | Plantar hyperkeratosis (HP:0007556) | 1.78770298 |
| 130 | 2-3 toe syndactyly (HP:0004691) | 1.77825885 |
| 131 | Birth length less than 3rd percentile (HP:0003561) | 1.77549995 |
| 132 | Prolonged bleeding time (HP:0003010) | 1.77304012 |
| 133 | Osteomyelitis (HP:0002754) | 1.76790975 |
| 134 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.76627318 |
| 135 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.75718826 |
| 136 | Abnormality of the Achilles tendon (HP:0005109) | 1.75459965 |
| 137 | Flat acetabular roof (HP:0003180) | 1.75358284 |
| 138 | J-shaped sella turcica (HP:0002680) | 1.75253445 |
| 139 | IgA deficiency (HP:0002720) | 1.74881635 |
| 140 | Hypertriglyceridemia (HP:0002155) | 1.73178254 |
| 141 | Ankyloglossia (HP:0010296) | 1.73071712 |
| 142 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.72845289 |
| 143 | Increased serum ferritin (HP:0003281) | 1.72410457 |
| 144 | Insomnia (HP:0100785) | 1.71225398 |
| 145 | Deviation of the thumb (HP:0009603) | 1.71081473 |
| 146 | Fatigue (HP:0012378) | 1.70839496 |
| 147 | Difficulty climbing stairs (HP:0003551) | 1.70727044 |
| 148 | Distal upper limb amyotrophy (HP:0007149) | 1.69072903 |
| 149 | Upper limb amyotrophy (HP:0009129) | 1.69072903 |
| 150 | Blepharitis (HP:0000498) | 1.68754644 |
| 151 | IgG deficiency (HP:0004315) | 1.67693053 |
| 152 | Abnormal blistering of the skin (HP:0008066) | 1.67685720 |
| 153 | Neoplasm of the oral cavity (HP:0100649) | 1.67616648 |
| 154 | High pitched voice (HP:0001620) | 1.67483660 |
| 155 | Thoracic kyphosis (HP:0002942) | 1.67298883 |
| 156 | Abnormality of the radial head (HP:0003995) | 1.66711781 |
| 157 | Recurrent skin infections (HP:0001581) | 1.66579466 |
| 158 | Abnormality of the columella (HP:0009929) | 1.66290107 |
| 159 | Gastrointestinal dysmotility (HP:0002579) | 1.65826011 |
| 160 | Ragged-red muscle fibers (HP:0003200) | 1.64731678 |
| 161 | Oral leukoplakia (HP:0002745) | 1.64319082 |
| 162 | Distal lower limb muscle weakness (HP:0009053) | 1.64159460 |
| 163 | Viral hepatitis (HP:0006562) | 1.64084547 |
| 164 | Fragile nails (HP:0001808) | 1.64049147 |
| 165 | Erythema (HP:0010783) | 1.63753885 |
| 166 | Neuronal loss in central nervous system (HP:0002529) | 1.63393111 |
| 167 | Nail dystrophy (HP:0008404) | 1.63276712 |
| 168 | Sparse scalp hair (HP:0002209) | 1.63077680 |
| 169 | Urticaria (HP:0001025) | 1.62855421 |
| 170 | Increased density of long bones (HP:0006392) | 1.62480786 |
| 171 | Abnormality of DNA repair (HP:0003254) | 1.61837907 |
| 172 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.61513585 |
| 173 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.61513585 |
| 174 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.61513585 |
| 175 | Pointed chin (HP:0000307) | 1.61413360 |
| 176 | Mucopolysacchariduria (HP:0008155) | 1.60856684 |
| 177 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.60856684 |
| 178 | Subacute progressive viral hepatitis (HP:0006572) | 1.60358247 |
| 179 | Abnormal platelet volume (HP:0011876) | 1.59836330 |
| 180 | Bone pain (HP:0002653) | 1.59629876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EEF2K | 4.79771251 |
| 2 | MAP4K1 | 4.06907713 |
| 3 | SMG1 | 3.80800761 |
| 4 | PRPF4B | 3.45326398 |
| 5 | CDK12 | 2.94982073 |
| 6 | MAP3K10 | 2.76777359 |
| 7 | ERN1 | 2.57300157 |
| 8 | RPS6KB2 | 2.55091970 |
| 9 | STK10 | 2.52436565 |
| 10 | IRAK3 | 2.44479064 |
| 11 | NEK2 | 2.14071615 |
| 12 | GRK6 | 2.00841089 |
| 13 | PKN2 | 1.88979140 |
| 14 | LRRK2 | 1.84788220 |
| 15 | BRD4 | 1.78700461 |
| 16 | TYK2 | 1.69566140 |
| 17 | IRAK4 | 1.68584085 |
| 18 | SIK2 | 1.65781476 |
| 19 | BTK | 1.60946938 |
| 20 | FGFR4 | 1.57214034 |
| 21 | TRIB3 | 1.57193943 |
| 22 | CDK4 | 1.47538079 |
| 23 | JAK3 | 1.46824327 |
| 24 | MAP3K11 | 1.46737857 |
| 25 | MAP3K13 | 1.45839280 |
| 26 | SIK3 | 1.40019670 |
| 27 | CSF1R | 1.35973669 |
| 28 | WEE1 | 1.31151898 |
| 29 | IKBKE | 1.27967919 |
| 30 | ZAP70 | 1.27540391 |
| 31 | EPHB1 | 1.26462861 |
| 32 | ITK | 1.26448976 |
| 33 | CDK19 | 1.25647935 |
| 34 | TSSK6 | 1.24418562 |
| 35 | MAPKAPK3 | 1.23681485 |
| 36 | MAP3K7 | 1.22902308 |
| 37 | SIK1 | 1.22860289 |
| 38 | EPHA2 | 1.16806764 |
| 39 | CDC42BPA | 1.15925037 |
| 40 | MAP3K8 | 1.14595405 |
| 41 | BUB1 | 1.12768908 |
| 42 | PRKD2 | 1.12345631 |
| 43 | CDK7 | 1.10866768 |
| 44 | ALK | 1.08957626 |
| 45 | RPS6KA4 | 1.06272391 |
| 46 | TESK2 | 1.05838759 |
| 47 | RIPK1 | 1.04563695 |
| 48 | CDC7 | 1.03955361 |
| 49 | CAMK1D | 1.02939205 |
| 50 | BLK | 1.02642351 |
| 51 | PASK | 1.01436709 |
| 52 | CLK1 | 0.99748037 |
| 53 | MTOR | 0.99058560 |
| 54 | CDK6 | 0.98179246 |
| 55 | TTN | 0.97509640 |
| 56 | ATR | 0.95028094 |
| 57 | KSR2 | 0.94706570 |
| 58 | PAK4 | 0.94164663 |
| 59 | MAP3K1 | 0.93360032 |
| 60 | PIM1 | 0.92846239 |
| 61 | SYK | 0.92498398 |
| 62 | TAOK1 | 0.91785129 |
| 63 | HCK | 0.91621122 |
| 64 | IRAK2 | 0.91241416 |
| 65 | PTK6 | 0.90241916 |
| 66 | MAP2K3 | 0.89914411 |
| 67 | KIT | 0.89597593 |
| 68 | TNK2 | 0.88271217 |
| 69 | MAP2K2 | 0.87547502 |
| 70 | MAP3K3 | 0.87101926 |
| 71 | FGFR2 | 0.85681220 |
| 72 | CAMK1G | 0.83710723 |
| 73 | JAK1 | 0.82807417 |
| 74 | LCK | 0.82005261 |
| 75 | RPS6KA2 | 0.81181469 |
| 76 | FLT3 | 0.79822120 |
| 77 | CHEK1 | 0.78057344 |
| 78 | PDGFRA | 0.75213644 |
| 79 | STK4 | 0.74637500 |
| 80 | RPS6KL1 | 0.71876879 |
| 81 | RPS6KC1 | 0.71876879 |
| 82 | TXK | 0.71765645 |
| 83 | PDPK1 | 0.70105148 |
| 84 | MST1R | 0.67675177 |
| 85 | MARK3 | 0.66538750 |
| 86 | NLK | 0.66424617 |
| 87 | MAP3K6 | 0.66347951 |
| 88 | NME2 | 0.65316631 |
| 89 | JAK2 | 0.63095896 |
| 90 | MARK2 | 0.62768883 |
| 91 | TGFBR1 | 0.60536605 |
| 92 | FGFR3 | 0.59416162 |
| 93 | CDK2 | 0.58022195 |
| 94 | HIPK2 | 0.57726610 |
| 95 | TTK | 0.55679046 |
| 96 | IKBKB | 0.55080611 |
| 97 | CDK9 | 0.53695555 |
| 98 | MAPK11 | 0.53529928 |
| 99 | ARAF | 0.52910578 |
| 100 | FGFR1 | 0.52549441 |
| 101 | RPS6KA6 | 0.51298867 |
| 102 | FGR | 0.50492625 |
| 103 | AURKB | 0.50465977 |
| 104 | PAK2 | 0.49415309 |
| 105 | RAF1 | 0.49015704 |
| 106 | PDK1 | 0.48007420 |
| 107 | PRKD3 | 0.47966310 |
| 108 | KDR | 0.47738291 |
| 109 | TRPM7 | 0.46797372 |
| 110 | DYRK3 | 0.46708458 |
| 111 | MAP3K14 | 0.46274840 |
| 112 | BRAF | 0.45758124 |
| 113 | TESK1 | 0.45690027 |
| 114 | CAMKK1 | 0.45501432 |
| 115 | MAPK12 | 0.45441373 |
| 116 | CHUK | 0.44918640 |
| 117 | PRKCI | 0.44108539 |
| 118 | MAPKAPK2 | 0.43647719 |
| 119 | TBK1 | 0.43319954 |
| 120 | TEC | 0.42854468 |
| 121 | TYRO3 | 0.42122349 |
| 122 | RIPK4 | 0.41936805 |
| 123 | TGFBR2 | 0.40821862 |
| 124 | FES | 0.40063962 |
| 125 | RET | 0.39547743 |
| 126 | CSK | 0.39310950 |
| 127 | RPS6KA1 | 0.38209975 |
| 128 | ICK | 0.37816395 |
| 129 | IRAK1 | 0.37700819 |
| 130 | ACVR1B | 0.37540291 |
| 131 | ATM | 0.36591793 |
| 132 | MATK | 0.35788181 |
| 133 | TAOK2 | 0.35151712 |
| 134 | BMX | 0.34841764 |
| 135 | MAP3K2 | 0.32960693 |
| 136 | LYN | 0.32756360 |
| 137 | PLK1 | 0.32353949 |
| 138 | CSNK1E | 0.30579709 |
| 139 | CHEK2 | 0.29547227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.28736769 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.14372975 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 2.74251059 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.69252697 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.57360083 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.47774780 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.43853949 |
| 8 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.21679926 |
| 9 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.15191404 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.04562911 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.03457799 |
| 12 | RNA transport_Homo sapiens_hsa03013 | 1.98217117 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 1.88744079 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.74499929 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.67316676 |
| 16 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.56357185 |
| 17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.54984495 |
| 18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.53752186 |
| 19 | Bladder cancer_Homo sapiens_hsa05219 | 1.53064011 |
| 20 | Cell cycle_Homo sapiens_hsa04110 | 1.52697809 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.44335033 |
| 22 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.44183133 |
| 23 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.43053742 |
| 24 | Lysine degradation_Homo sapiens_hsa00310 | 1.41988205 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.41417205 |
| 26 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.38299944 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.36973490 |
| 28 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.34580224 |
| 29 | RNA polymerase_Homo sapiens_hsa03020 | 1.34382520 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.34009630 |
| 31 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.33667327 |
| 32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.33559914 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.27532350 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.26275926 |
| 35 | Homologous recombination_Homo sapiens_hsa03440 | 1.23793702 |
| 36 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.18313837 |
| 37 | Measles_Homo sapiens_hsa05162 | 1.17821504 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.16663831 |
| 39 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.15231288 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.14772910 |
| 41 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.13223011 |
| 42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.12738927 |
| 43 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.10212009 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 1.08846592 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08046134 |
| 46 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.07694565 |
| 47 | HTLV-I infection_Homo sapiens_hsa05166 | 1.07466177 |
| 48 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.06926067 |
| 49 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.04209140 |
| 50 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.03207950 |
| 51 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.01000420 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.97856360 |
| 53 | Glioma_Homo sapiens_hsa05214 | 0.97830000 |
| 54 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.96562266 |
| 55 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.96561429 |
| 56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96521860 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 0.93037865 |
| 58 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.92347491 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.91418779 |
| 60 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.90354417 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 0.90040870 |
| 62 | Malaria_Homo sapiens_hsa05144 | 0.87953751 |
| 63 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.87668991 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87605756 |
| 65 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.87593092 |
| 66 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87408501 |
| 67 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86507760 |
| 68 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.85873725 |
| 69 | Viral myocarditis_Homo sapiens_hsa05416 | 0.85022620 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84938509 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.84498599 |
| 72 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.83670740 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.83325993 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82957990 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82089060 |
| 76 | Salmonella infection_Homo sapiens_hsa05132 | 0.81438541 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 0.81043622 |
| 78 | Influenza A_Homo sapiens_hsa05164 | 0.80621458 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.80164112 |
| 80 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.79366186 |
| 81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79254840 |
| 82 | Leishmaniasis_Homo sapiens_hsa05140 | 0.77928881 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.77867092 |
| 84 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.76654059 |
| 85 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.75758623 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75407249 |
| 87 | RNA degradation_Homo sapiens_hsa03018 | 0.73014149 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73000091 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72524946 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.71650027 |
| 91 | Apoptosis_Homo sapiens_hsa04210 | 0.71502981 |
| 92 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.70398042 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.69414973 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | 0.68561608 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68409081 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67266619 |
| 97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.62946922 |
| 98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.62615181 |
| 99 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62596286 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.62486064 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.61022359 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60765770 |
| 103 | Shigellosis_Homo sapiens_hsa05131 | 0.59932408 |
| 104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59575340 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59432421 |
| 106 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59352398 |
| 107 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58573855 |
| 108 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58495174 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57846519 |
| 110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56537173 |
| 111 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.55851058 |
| 112 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55393215 |
| 113 | Pertussis_Homo sapiens_hsa05133 | 0.54892279 |
| 114 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54351260 |
| 115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54105418 |
| 116 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.53387992 |
| 117 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52228904 |
| 118 | Pathways in cancer_Homo sapiens_hsa05200 | 0.51341428 |
| 119 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50437566 |
| 120 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49839848 |
| 121 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.47899881 |
| 122 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47651364 |
| 123 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44274194 |
| 124 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.43317737 |
| 125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42851724 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42555454 |
| 127 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41330185 |
| 128 | Prostate cancer_Homo sapiens_hsa05215 | 0.39392655 |
| 129 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38922084 |
| 130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38216573 |
| 131 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.37611140 |
| 132 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.37095094 |
| 133 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.35635405 |
| 134 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.34528638 |

